In conclusion, our study is the first, to our knowledge, that used CD3, CD8, and FOXP3 mRNA expression as surrogate markers of T‐cell infiltration and examined the prognostic value of such markers in BC. This evidence concerns the gene FOXP3 and breast cancer.